Knightsbridge Asset Management, LLC Johnson & Johnson Transaction History

Knightsbridge Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $55,619 - $60,692	-382 Reduced 21.58%	1,388 $217,000
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $387,817 - $434,455	-2,490 Reduced 58.45%	1,770 $276,000
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $543,157 - $584,541	-3,519 Reduced 45.24%	4,260 $705,000
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $119,178 - $142,225	789 Added 11.29%	7,779 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $158,117 - $177,452	987 Added 16.44%	6,990 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $1,935 - $2,154	-12 Reduced 0.2%	6,003 $981,000
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $503,224 - $556,541	2,992 Added 98.97%	6,015 $1.07 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $1,739 - $1,975	-11 Reduced 0.36%	3,023 $536,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $61,436 - $68,165	-394 Reduced 11.49%	3,034 $519,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $198,483 - $220,568	1,229 Added 55.89%	3,428 $554,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $14,193 - $15,225	89 Added 4.22%	2,199 $362,000
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $98,117 - $109,277	641 Added 43.64%	2,110 $347,000
Q4 2020 Feb 17, 2021	SELL	$137.11 - $157.38 $79,386 - $91,123	-579 Reduced 28.27%	1,469 $231,000
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $22,460 - $24,612	160 Added 8.47%	2,048 $305,000
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $243,193 - $293,602	1,888 New	1,888 $266,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $420B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Knightsbridge Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knightsbridge Asset Management, LLC with notifications on news.